MOSCOW (Sputnik) - The EpiVacCorona vaccine against COVID-19, developed by Russian research center Vector, is now in Phase III post-registration clinical trials, the head of the federal public h
MOSCOW (Sputnik) - The EpiVacCorona vaccine against COVID-19, developed by Russian research center Vector, is now in Phase III post-registration clinical trials, the head of the federal public h
MOSCOW (Sputnik) - The EpiVacCorona vaccine against COVID-19, developed by Russian research center Vector, is now in Phase III post-registration clinical trials, the head of the federal public h
Moscow (Sputnik) – Russian educational and science organisations engaged in hydrogen energy research have united into a group to develop the entire chain of hydrogen technologies in Russia, star
Moscow (Sputnik) – Russian educational and science organisations engaged in hydrogen energy research have united into a group to develop the entire chain of hydrogen technologies in Russia, star
Moscow (Sputnik) – Russian educational and science organisations engaged in hydrogen energy research have united into a group to develop the entire chain of hydrogen technologies in Russia, star
Moscow (Sputnik) – Russian educational and science organisations engaged in hydrogen energy research have united into a group to develop the entire chain of hydrogen technologies in Russia, star
Moscow (Sputnik) – Russian educational and science organisations engaged in hydrogen energy research have united into a group to develop the entire chain of hydrogen technologies in Russia, star
MOSCOW (Sputnik) - Russian State Research Center of Virology and Biotechnology Vector has discovered more than 15 compounds with pronounced antiviral activity, which are promising for the creati
MOSCOW (Sputnik) - Russian State Research Center of Virology and Biotechnology Vector has discovered more than 15 compounds with pronounced antiviral activity, which are promising for the creati
